Autism spectrum disorders (ASD) reflect a critical gap in medical care, often involving challenges in social communication, with limited treatments available for core symptoms. A key barrier to ...
In another important milestone, PeriVision has signed a clinical trial agreement with Genentech, Roche's US business unit. The aim is to evaluate the potential use of the VisionOne platform in ...
Marcel Aumer, CEO, VRP und Co-Founder der FlexBase Group, rechnet trotz der Projektneuauflage nicht mit einer Verzögerung des ambitionierten Zeitplans. Der Baustart ist für Frühling 2025 geplant. Als ...
Mabylon AG is a Schlieren-based biotechnology company at the forefront of human-derived antibody research, with a primary focus on allergies, neurological and inflammatory disorders. The company has ...
Unlike traditional aligners, which often cause oral hygiene problems such as bacteria build-up, bad breath (halitosis) or cavities, Actival incorporates CSEM's patented 3D-printed microchannel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback